Compare stocks

Heidelberg Pharma AG is a biotechnology company focused on developing novel cancer therapies. It specializes in a proprietary technology known as Antibody Targeted Amanitin Conjugates (ATACs), aimed at delivering potent toxins specifically to cancer cells. Founded in Germany, the company is headquartered in Ladenburg and operates primarily in the pharmaceutical sector, with a strong emphasis on research and development collaborations. Heidelberg Pharma positions itself by leveraging its unique ATAC platform, differentiating itself through targeted cancer treatment modalities. The company collaborates with pharmaceutical firms to enhance its development pipeline and commercial reach across various markets. Sources: https://www.heidelberg-pharma.com/

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.